Перегляньте повний профіль Taras. Review requirements, specifications, and technical design documents to provide timely and meaningful feedback. Create detailed, comprehensive, and well-structured test plans and test cases. Identity, record, document thoroughly, and track bugs. Perform thorough regression testing when .
Aromasin in Women with Post-menopausal HR+ Early Stage Breast Cancer. Breast cancer patients who switch to Aromasin® after 2-3 years of Nolvadex® are less likely to experience cancer recurrence, develop cancer in the opposite breast, and have better overall survival, than women who remain on Nolvadex.
Hi there! My name is Julia. I have been working in the field of HR for 10 years. I know the entire range of work - search, adaptation, document management, formation of personnel reserves, analytics, etc.
Currently, I participate in the implementation of LEAN technologies on the basis of our enterprise. In the process, I implemented a Telegram chatbot for consulting on personnel issues.
Anastrozole (Arimidex) and exemestane (Aromasin) are aromatase inhibitors (AIs) used for treating estrogen receptor-positive (ER+) breast cancer in people who have gone through menopause. Research shows that both anastrozole and exemestane are similarly effective in achieving cancer-free survival. Arimidex and Aromasin are both available as .
Aromatase inhibitors reduce recurrence rates by about 30% (proportionately) compared with tamoxifen while treatments differ, but not thereafter. 5 years of an aromatase inhibitor reduces 10-year breast cancer mortality rates by about 15% compared with 5 years of tamoxifen, hence by about 40% (proportionately) compared with no endocrine treatment.
Class: Hormonal Therapy Generic Name: exemestane (ecks-uh-MESS-tane) Trade Name: Aromasin® For which conditions is Aromasin approved for? Aromasin is indicated for the treatment of hormone-positive breast cancer in postmenopausal women who have already been treated with the anti-estrogen agent tamoxifen (Nolvadex®).
Aromatase inhibitors (AIs) are now U. S. Food & Drug Administration approved and have been shown to be more effective than the antiestrogen drug tamoxifen in the postmenopausal population. There are three medications that are second-generation AIs, including anastrozole (Arimidex), letrozole (Femara), and exemestane (Aromasin).
Aromasin and tamoxifen both work by stopping estrogen from encouraging cancer cells to grow and spread. But the two drugs each work in slightly different ways. Aromasin is a kind of drug known as .
I know how to use social media and achieve business goals faster and more efficiently. I can create and implement marketing strategies that will gain good results. I can provide content that will responds to the target audience's needs. I'm a fast learner and familiar with trends. Soft Skills: Creative Enthusiastic Organized >Communicative
Problem-solving skills
Analytical skills
Nolvadex d is used to treat the following conditions: McCune-Albright Syndrome. Talk to your doctor before using tamoxifen with soy products. There is some evidence that substances present in soy may stimulate breast tumor growth and interfere with the action of tamoxifen, although this has not been proven. Whether soy products are effective .
Hello! For me, both the process and the progress and the result are very important. An excellent result is the way to success, otherwise, it's another study! My motto is getting up and just do it! About Data Science. Looking for a job as a Junior Data Scientist. I am considering options - practice, internship, junior specialist. Completed courses in Data Scientist (Python).
AROMASIN is an aromatase inhibitor indicated for: • adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to AROMASIN for completion of a total of five consecutive years of adjuvant hormonal therapy (). treatment of advanced breast cancer in postmenopausal women whose disease has .
Aromasin is sometimes given after you have taken tamoxifen for 2 or 3 years, or if tamoxifen did not work or has stopped working. Warnings. You should not use Aromasin if you are allergic to exemestane, if you have not started menopause, or if you are pregnant or able to become pregnant. Do not use Aromasin if you are pregnant.
Exemestane (Aromasin) Like tamoxifen, these drugs are more often used to treat hormone receptor-positive breast cancer than to lower breast cancer risk. . Unlike tamoxifen and raloxifene, AIs tend to speed up bone thinning, which can lead to osteoporosis. People with osteoporosis are more likely to have broken bones.
Metabolism of estrogens in men. Aromatase, also known as estrogen synthetase, is the key enzyme in estrogen biosynthesis. The enzyme, localized in the endoplasmic reticulum of the estrogen-producing cell, is encoded by the CYP19A1 gene. This gene is a member of the CYP gene family, encoding a class of enzymes active in the hydroxylation of endogenous and exogenous substances.
Tamoxifen (Nolvadex, Soltamox) is another drug used for breast cancer treatment. For this use, Arimidex can be taken for cancer that's HR+, HR negative (HR-), or HR-unknown.
Exemestane (Aromasin). Letrozole (Femara). These medicines can reduce the risk of cancer recurrence in those who have been treated for early-stage breast cancer. Aromatase inhibitors also can be used to treat advanced breast cancer. And they may be an option for people who no longer benefit from tamoxifen treatment or whose treatment is completed.
Aromasin is given for two to three years following tamoxifen therapy for a total of five years of tamoxifen and Aromasin therapy. Known by the brand name, Nolvadex, tamoxifen is an estrogen modulator that binds to estrogen receptors on cancer cells so that estrogen cannot bind to the receptor and promote cancer cell growth. Arimidex is FDA .
While tamoxifen has been shown to improve lipid profiles, the aromatase inhibitors have a very different mode of action and do not possess the oestrogen-agonistic effects of tamoxifen. . Zobolas V, Bafaloukos D, Papadiamantis J (2003) The effect of exemestane (Aromasin®) on the lipidemic profile of breast cancer patients: preliminary results .
Arimidex (anastrozole) and Nolvadex (tamoxifen citrate) are used to treat breast cancer. . Arimidex is used in postmenopausal women and is often given to women whose cancer has progressed even after taking tamoxifen (Nolvadex, Soltamox). . Nolvadex is used to treat breast cancer that has spread to other parts of the body (metastatic breast cancer), to treat breast cancer in certain patients .
Exemestane (Aromasin) and tamoxifen are both prescription drugs used to treat certain kinds of breast cancer. Aromasin is available as a tablet that you take by mouth. It comes in both brand-name .
Aromasin (exemestane) is a prescription drug that's used to treat certain types of breast cancer. Aromasin can cause side effects that range from mild to serious. Examples include weight gain .
What Is Aromasin? Aromasin (exemestane) is an antineoplastic (anticancer) agent used to treat breast cancer in postmenopausal women. Aromasin is often given to women whose cancer has progressed even after taking tamoxifen (Nolvadex, Soltamox) for 2 to 3 years. . What Are Side Effects of Aromasin?